Proposal for Addition Of Risdiplam to WHO Model List Of Essential Medicines, for the treatment of Spinal Muscular Atrophy (SMA).

On November 1, 2024, Knowledge Ecology International (KEI) submitted a proposal for the addition of risdiplam to the World Health Organization’s (WHO) Model List of Essential Medicine (EML). You can access the full proposal here: risdiplam2WHOEML1Nov2024 The EML, updated every… Continue Reading

KEI Comments to NIH on Exclusive License to T-Cure Biosciences for Anti-KK-LC-1 T Cell Receptors Patents

KEI-NIH-T-Cure-Biosciences22Oct2024 Knowledge Ecology International (KEI) objects to the “Prospective Grant of an Exclusive Patent License: Anti-KK-LC-1 T Cell Receptors” (89 FR 81089) to T-Cure Biosciences, Inc. (T-Cure). Among other things, KEI said the NIH needs to be more forthcoming in… Continue Reading

KEI Letter to USPTO on WIPO Design Law Treaty Federal Funding Disclosure Issue

Knowledge Ecology International (KEI) has sent a letter to Katherine Vidal, Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (USPTO) concerning an issue in Article 3 of the the World Intellectual Property… Continue Reading

Save the Date: Thursday, 17 October 2024 – Innovarte/KEI side event: Best and worst practices for limitations and exceptions to patent rights

Title: Best and worst practices for limitations and exceptions to patent rights Date: Thursday, 17 October 2024 Time: 13:30 CEST to 15:00 CEST Location: Room B, WIPO Registration link: https://wipo-int.zoom.us/meeting/register/u5Mtf-6vqz0jGdWIE2AObIjgN86Xuy4yqaKi Conveners: Innovarte and Knowledge Ecology International (KEI) On the margins… Continue Reading